|
- Zongertinib in Previously Treated HER2-Mutant Non–Small-Cell Lung . . .
We evaluated zongertinib in a multicohort, phase 1a–1b trial involving patients with advanced or metastatic HER2 -mutant NSCLC
- Zongertinib - Wikipedia
Zongertinib, sold under the brand name Hernexeos, is an anti-cancer medication used for the treatment of non-small cell lung cancer [1][2] Zongertinib is a kinase inhibitor of human epidermal growth factor receptor 2 (HER2) [1][3][4] It is taken by mouth
- FDA grants accelerated approval to zongertinib for non-squamous NSCLC
On August 8, 2025, the Food and Drug Administration granted accelerated approval to zongertinib (Hernexeos, Boehringer Ingelheim Pharmaceuticals, Inc ), a kinase inhibitor, for adults with
- Treatment for HER2 Metastatic NSCLC | HERNEXEOS® (zongertinib tablets)
What is HERNEXEOS (zongertinib tablets)? HERNEXEOS is a prescription medicine used to treat adults with a type of lung cancer called non-squamous non-small cell lung cancer (NSCLC) that: who have previously received treatment by mouth or injection (systemic therapy)
- Zongertinib (oral route) - Side effects dosage - Mayo Clinic
Zongertinib belongs to the group of medicines called antineoplastics (cancer medicines) It works by interfering with the growth of cancer cells, which are eventually destroyed
- Zongertinib: MedlinePlus Drug Information
Zongertinib is in a class of medications called kinase inhibitors It works by blocking the action of an abnormal protein that signals cancer cells to multiply
- Hernexeos (Zongertinib): Uses, Dosage, Side Effects, Warnings - Drugs. com
Hernexeos is a tyrosine kinase inhibitor (TKI) that works by selectively blocking HER2 (ERBB2), to help control tumor growth and improve survival time for patients Hernexeos tablets are taken once daily with or without food
- Zongertinib - Memorial Sloan Kettering Cancer Center
Zongertinib Adult Medication This information from Lexicomp ® explains what you need to know about this medication, including what it’s used for, how to take it, its side effects, and when to call your healthcare provider
|
|
|